FDA Inspection
Ames Goldsmith CorporationAmes Goldsmith Corporation – FDA Inspection, May 22, 2025
Record Details
This FDA Inspection record concerns Ames Goldsmith Corporation, with an inspection on May 22, 2025, issued by the New York District Office, covering human drugs.
View Company Profile
ID · ccf9f25c-28da-4c04-8770-6db09b0efe61
Inspection Facts
- Inspection number
- 1271423
- FDA center
- Human Drugs
Other FDA inspections of Ames Goldsmith Corporation
8| Date | Classification | Office | Project area |
|---|---|---|---|
| March 6, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 16, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 25, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 10, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 26, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ames Goldsmith Corporation
- FDA Inspection 1121591 - 2020-03-06
- FDA Inspection 975290 - 2016-06-16
- FDA Inspection 885727 - 2014-06-25
- FDA Inspection 813894 - 2013-01-10
- FDA Inspection 764753 - 2012-01-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.